PRL and hyperprolactinemia: Common choices for the management of hyperprolactinaemia include switching the patient to a prolactin-sparing antipsychotic or additional use of D2 receptor agonist such as bromocriptine or cabergoline, however with increasing risk of adverse effects (Haddad and Wieck, 2004).